We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$14.3M
Cap. Flow
+$10.4M
Cap. Flow %
4.51%
Top 10 Hldgs %
31.83%
Holding
146
New
35
Increased
57
Reduced
31
Closed
6
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.19M
2
TGT icon
Target
TGT
+$645K
3
XLNX
Xilinx Inc
XLNX
+$524K
4
FISV icon
Fiserv Inc
FISV
+$483K
5
IPGP icon
IPG Photonics
IPGP
+$386K

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 23.62%
3 Industrials 17.11%
4 Energy 10.93%
5 Miscellaneous 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FRC
101
DELISTED
First Republic Bank
FRC
$168K 0.07%
+3,120
New +$161K
2014 Q1
0 quarters
KMB icon
102
Kimberly-Clark
KMB
$34.4B
$158K 0.07%
1,498
– –
2013 Q4
1 quarter
KRFT
103
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$158K 0.07%
+2,819
New +$153K
2014 Q1
0 quarters
DIS icon
104
Walt Disney
DIS
$192B
$156K 0.07%
+1,950
New +$151K
2014 Q1
0 quarters
LMT icon
105
Lockheed Martin
LMT
$123B
$153K 0.07%
+935
New +$147K
2014 Q1
0 quarters
ACC
106
DELISTED
American Campus Communities, Inc.
ACC
$153K 0.07%
+4,105
New +$145K
2014 Q1
0 quarters
TUP icon
107
DELISTED
Tupperware Brands Corporation
TUP
$150K 0.06%
+1,790
New +$147K
2014 Q1
0 quarters
BP icon
108
BP
BP
$125B
$146K 0.06%
+3,704
New +$146K
2014 Q1
0 quarters
CVSA icon
109
Covista Inc
CVSA
$4.35B
$139K 0.06%
+3,275
New +$127K
2014 Q1
0 quarters
AXP icon
110
American Express
AXP
$210B
$133K 0.06%
1,473
– –
2013 Q4
1 quarter
MD icon
111
Pediatrix Medical
MD
$2.24B
$131K 0.06%
+2,115
New +$123K
2014 Q1
0 quarters
CL icon
112
Colgate-Palmolive
CL
$73.9B
$120K 0.05%
1,850
– –
2013 Q3
2 quarters
TSCO icon
113
Tractor Supply
TSCO
$17.2B
$116K 0.05%
+8,200
New +$116K
2014 Q1
0 quarters
MIDD icon
114
Middleby
MIDD
$4.87B
$95K 0.04%
+1,080
New +$94.2K
2014 Q1
0 quarters
AFL icon
115
Aflac
AFL
$59.4B
$91K 0.04%
2,900
-2,600
-47% -$82.6K
2013 Q2
3 quarters
PX icon
116
DELISTED
Praxair Inc
PX
$72K 0.03%
550
-100
-15% -$13K
2013 Q2
3 quarters
MKTX icon
117
MarketAxess Holdings
MKTX
$5.8B
$68K 0.03%
+1,150
New +$71.1K
2014 Q1
0 quarters
ZTS icon
118
Zoetis
ZTS
$32.5B
$61K 0.03%
+2,125
New +$64.9K
2014 Q1
0 quarters
HIBB icon
119
DELISTED
Hibbett, Inc. Common Stock
HIBB
$55K 0.02%
+1,040
New +$61.3K
2014 Q1
0 quarters
TYY
120
DELISTED
TORTOISE ENERGY CAPITAL CORP
TYY
$47K 0.02%
+1,428
New +$46.1K
2014 Q1
0 quarters
PRO icon
121
DELISTED
PROS Holdings
PRO
$41K 0.02%
+1,300
New +$47.1K
2014 Q1
0 quarters
CINF icon
122
Cincinnati Financial
CINF
$25.6B
$39K 0.02%
+805
New +$38.8K
2014 Q1
0 quarters
MO icon
123
Altria Group
MO
$123B
$39K 0.02%
+1,030
New +$37.4K
2014 Q1
0 quarters
PM icon
124
Philip Morris
PM
$312B
$35K 0.02%
+430
New +$34.7K
2014 Q1
0 quarters
RGC icon
125
DELISTED
Regal Entertainment Group
RGC
$35K 0.02%
+1,865
New +$35.8K
2014 Q1
0 quarters

Similar funds

Michael B. Elefante's Q1 2014 Portfolio in Review

As of Q1 2014, Michael B. Elefante held 146 positions worth $231M, up 6.6% from $217M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante deployed $10.4M of net new capital in Q1 2014, opening 35 new positions and adding to 57 existing holdings. Its largest new stake was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $595K trimmed.

  • Michael B. Elefante's largest Q1 2014 buy was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
  • Michael B. Elefante added most to Qualcomm in Q1 2014, an estimated $1.19M increase.
  • Michael B. Elefante's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $595K.
  • Michael B. Elefante fully exited Stryker in Q1 2014, selling an estimated $258K.
  • Michael B. Elefante's ten largest holdings make up 32% of its $231M portfolio in Q1 2014.
  • Michael B. Elefante opened 35 new positions and closed 6 in Q1 2014.
  • Michael B. Elefante's portfolio value rose 6.6% quarter-over-quarter to $231M.

Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.